ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,791.58
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ESSA Pharma Inc (EPIX)

  7. ESSA Pharma Inc (EPIX) News

ESSA Pharma (EPIX)

ESSA Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EPIX
DateTimeSourceHeadlineSymbolCompany
06/05/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
09/04/202413:00PR Newswire (US)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
09/04/202413:00PR Newswire (Canada)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
08/03/202401:13PR Newswire (US)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
08/03/202401:13PR Newswire (Canada)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
07/03/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
05/03/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
13/02/202412:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
13/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
13/02/202412:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
13/02/202412:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
07/02/202416:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
06/02/202413:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
06/02/202413:00PR Newswire (US)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
06/02/202413:00PR Newswire (Canada)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
29/01/202414:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
26/01/202421:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EPIXESSA Pharma Inc
26/01/202421:27Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EPIXESSA Pharma Inc
25/01/202415:00PR Newswire (US)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
25/01/202415:00PR Newswire (Canada)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
23/01/202421:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EPIXESSA Pharma Inc
18/01/202401:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
16/01/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
16/01/202418:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
09/01/202401:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
05/01/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
12/12/202312:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
12/12/202312:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EPIXESSA Pharma Inc
12/12/202312:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023NASDAQ:EPIXESSA Pharma Inc
12/12/202312:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023NASDAQ:EPIXESSA Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EPIX

Your Recent History

LSE
LTI
Lindsell Train Investment
LSE
GFM
Griffin Mining
LSE
PET
Petrel Resources
LSE
JSE
Jadestone Energy
LSE
GOLD
LSE
BARC
Barclays
LSE
THUS
Thus
LSE
BT.A
Bt
LSE
WG.
Wood Group (john)
LSE
SCE
Surface Transforms
LSE
GKP
Gulf Keystone Petroleum
LSE
MIRI
Mirriad Advertising
LSE
OCI
Oakley Capital Investments
NASDAQ
ETSY
Etsy
LSE
PTEC
Playtech
LSE
PXC
Phoenix Copper
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved